From April 1, 2022 to June 14, 2022, the company has repurchased 2,212,100 shares, representing 3.72% for CNY 67.83 million. With this, the company has completed the repurchase of 2,800,000 shares, representing 4.7% for CNY 88.09 million under the buyback announced on November 26, 2021.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
16.26 CNY | +0.68% | +0.49% | -33.14% |
1st Jan change | Capi. | |
---|---|---|
-33.14% | 178M | |
+0.73% | 101B | |
-11.98% | 58.77B | |
+75.71% | 47.81B | |
+5.26% | 35.9B | |
+3.47% | 18.77B | |
+17.33% | 16.92B | |
+5.92% | 13.49B | |
-6.67% | 12.88B | |
-25.86% | 11.93B |
- Stock Market
- Equities
- 003017 Stock
- News Zhe Jiang Dayang Biotech Group Co., Ltd.
- Tranche Update on Zhejiang Dayang Biology Technology Co.,Ltd.'s Equity Buyback Plan announced on November 26, 2021.